Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 C-RAD B CRADB Apr 24, 2025 29.65 -0.17   
 Cadeler CADLRO Apr 24, 2025 52.95 -0.84   
 CAG Group CAG Apr 24, 2025 110.00 0.00   
 Camurus CAMX Apr 24, 2025 588.00 +1.29   
 Candles Scandinavia CANDLEB Apr 24, 2025 16.45 -0.30   
 Cantargia CANTA Apr 24, 2025 1.56 -0.51   
 Carasent CARA Apr 24, 2025 22.85 -2.35   
 Carbiotix CRBX Apr 24, 2025 10.20 0.00   
 Cardeon CARDEO Apr 24, 2025 0.10 +7.53   
 Careium AB CARE Apr 24, 2025 28.10 -0.35   
 Case CASE Apr 24, 2025 15.20 -1.94   
 Castellum CAST Apr 24, 2025 116.55 +1.52   
 Catella A CATA Apr 24, 2025 26.20 -4.38   
 Catella B CATB Apr 24, 2025 29.52 +1.71   
 Catena CATE Apr 24, 2025 446.40 +0.18   
 Catena Media CTM Apr 24, 2025 2.09 +0.97   
 Cavendish Hydrogen CAVENO Apr 24, 2025 5.31 +26.43   
 Cavotec SA CCC Apr 24, 2025 15.75 -0.63   
 CDON CDON Apr 24, 2025 49.50 +2.70   
 Cedergrenska CEDER Apr 24, 2025 31.80 -2.45   
 Cell Impact CI Apr 24, 2025 0.08 -5.88   
 CellaVision CEVI Apr 24, 2025 165.00 +1.60   
 Cereno Scientific B CRNOB Apr 24, 2025 7.97 -1.36   
 ChargePanel AB (publ) CHARGE Apr 24, 2025 1.19 -2.06   
 Checkin.com Group CHECK Apr 24, 2025 9.30 0.00   
 Cheffelo CHEF Apr 24, 2025 46.00 +2.00   
 Chordate Medical Holding CMH Apr 24, 2025 5.54 +1.47   
 Chordate Medical Holding Pref CMHPREF Apr 24, 2025 3.01 0.00   
 Chosa Oncology AB CHOSA Apr 24, 2025 0.76 +16.92   
 Cibus Nordic Real Estate CIBUS Apr 24, 2025 160.75 +0.03   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.